These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 2972301

  • 1. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM, Ishag AH, Durgham SM.
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [Abstract] [Full Text] [Related]

  • 2. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
    Simon VC, Simon M.
    Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
    [Abstract] [Full Text] [Related]

  • 3. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V.
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [Abstract] [Full Text] [Related]

  • 4. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M, Yazgi H, Aktaş E, Ayyildiz A, Parlak M.
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [Abstract] [Full Text] [Related]

  • 5. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ, Blakemore PH.
    Drugs Exp Clin Res; 1990 Oct; 16(11):557-63. PubMed ID: 2151661
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 7. Adverse effect of staphylococci slime on in vitro activity of glycopeptides.
    Mathur T, Singhal S, Khan S, Upadhyay D, Fatma T, Rattan A.
    Jpn J Infect Dis; 2005 Dec; 58(6):353-7. PubMed ID: 16377866
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL, Kiffer CR, Mendes CM, Nicolau DP.
    Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ, Durgham SM, Shibl AM.
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [Abstract] [Full Text] [Related]

  • 10. In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.
    Lopez S, Hackbarth C, Romanò G, Trias J, Jabes D, Goldstein BP.
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii21-4. PubMed ID: 15750033
    [Abstract] [Full Text] [Related]

  • 11. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W, Leitha T, Breyer S, Francesconi M, Lenz K, Georgopoulos A.
    Drugs Exp Clin Res; 1985 Mar; 11(1):23-7. PubMed ID: 3869801
    [Abstract] [Full Text] [Related]

  • 12. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A, Cassone M, Monaco M, Tarasi D, Pompeo ME, Venditti M.
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C, Caillon J, Le Mabecque V, Miegeville AF, Donnio PY, Bugnon D, Potel G.
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [Abstract] [Full Text] [Related]

  • 14. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S.
    Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
    [Abstract] [Full Text] [Related]

  • 15. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
    Bourgeois F, Bingen E, Lambert-Zechovsky N.
    Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
    [Abstract] [Full Text] [Related]

  • 16. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D, Toshkova K, Gavrilova V.
    Vutr Boles; 2000 Jan; 32(2):35-40. PubMed ID: 11227664
    [Abstract] [Full Text] [Related]

  • 17. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC, Mulvihill TE, Jones L, Mooney D, Falkiner FR, Keane CT.
    J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
    [Abstract] [Full Text] [Related]

  • 18. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC, Exner GU, Reize CL, Merkofer C, Scott CP, Zbinden R.
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [Abstract] [Full Text] [Related]

  • 19. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
    Claessens J, Roriz M, Merckx R, Baatsen P, Van Mellaert L, Van Eldere J.
    Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
    [Abstract] [Full Text] [Related]

  • 20. [Methicillin resistant Staphylococcus aureus and glycopeptides (vancomycin, teicoplanin): in vitro selection of resistance].
    Serazin V, Mougeot C, Libert JM.
    Pathol Biol (Paris); 1994 Apr; 42(4):323-7. PubMed ID: 7808785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.